Pinteon Therapeutics is a biotechnology company advancing clinical studies of a novel antibody.
Pinteon Therapeutics has raised $29.2M in total funding. The most recent round was Series B. The last funding was announced in January 2022.
Pinteon Therapeutics's investors include Morningside.
Pinteon Therapeutics is headquartered in Newton, United States.
Pinteon Therapeutics is a biotechnology company advancing clinical studies of a novel antibody.
Pinteon Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pinteon Therapeutics — Funding & Investors." VCBacked, January 11, 2022, https://www.vcbacked.co/company/pinteon-therapeutics. Accessed September 30, 2026.
VCBacked. (2022). Pinteon Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/pinteon-therapeutics
{{cite web |title=Pinteon Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/pinteon-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated